No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
暂无分享,去创建一个
T. Ørntoft | L. Aaltonen | K. Birkenkamp-Demtröder | P. Vahteristo | K. Salmenkivi | J. Arola | A. Karhu | T. Orntoft | M. Georgitsi | A. Raitila | K. Tuppurainen | M. Mäkinen | V. Launonen | V Launonen | L A Aaltonen | M Georgitsi | A Karhu | P Vahteristo | T F Orntoft | J Arola | A Raitila | K Tuppurainen | M J Mäkinen | K Birkenkamp-Demtröder | K Salmenkivi | M. Georgitsi
[1] A. Jauch,et al. Genetics of neuroendocrine and carcinoid tumours. , 2003, Endocrine-related cancer.
[2] L. Chow,et al. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer , 1999, Oncogene.
[3] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[4] Qifeng Yang,et al. BRCA1 in non-inherited breast carcinomas (Review). , 2002, Oncology reports.
[5] L. Raffel,et al. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. , 2006, The Journal of clinical endocrinology and metabolism.
[6] C. Stratakis,et al. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. , 2001, The Journal of clinical endocrinology and metabolism.
[7] A. Grossman,et al. The diagnosis and medical management of advanced neuroendocrine tumors. , 2004, Endocrine reviews.
[8] Jan Lubinski,et al. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations , 2007, Proceedings of the National Academy of Sciences.
[9] L. Aaltonen,et al. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers , 2007, British Journal of Cancer.
[10] A. Lania,et al. Pathogenesis of Prolactinomas , 2005, Pituitary.
[11] C. Larsson,et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.
[12] R Kucherlapati,et al. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. , 2000, The Journal of clinical investigation.
[13] B. Estour,et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. , 2007, The Journal of clinical endocrinology and metabolism.
[14] R. Paschke,et al. Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene , 2006, Science.
[15] C. Stratakis,et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex , 2000, Nature Genetics.
[16] L. Niskanen,et al. A nationwide survey of mortality in acromegaly. , 2005, The Journal of clinical endocrinology and metabolism.
[17] M. Nasrallah,et al. Pituitary tumors: pathophysiology, clinical manifestations and management. , 2001, Endocrine-related cancer.
[18] P. Dahia,et al. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. , 2007, The Journal of clinical endocrinology and metabolism.
[19] T. Sano,et al. The aryl hydrocarbon receptor‐interacting protein gene is rarely mutated in sporadic GH‐secreting adenomas , 2007, Clinical endocrinology.
[20] C. Stratakis,et al. Carney Complex: Pathology and Molecular Genetics , 2006, Neuroendocrinology.
[21] V. Bours,et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. , 2007, The Journal of clinical endocrinology and metabolism.